Adiponectin is an adipokine with insulin-sensitizing and antiatherogenic actions, which also influences energy homeostasis via the hypothalamus (Kadowaki et al. 2008). The human adiponectin receptors AdipoR1 and AdipoR2 are PAQR proteins: 7-transmembrane domain proteins with topologies reversed that of GPCRs, i.e. their C-terminus is extracellular (Tang et al. 2005). We have previously shown that a loss of function mutant of the C. elegans adiponectin receptor homolog
paqr-2 is unable to adapt to growth at 15 deg C (Svensson et al. 2011). We have now leveraged the
paqr-2 cold adaptation defect in a suppressor screen with the aim of identifying downstream receptor targets. The screen produced nine suppressor mutations that have all been identified through whole genome sequencing and experimental verification. The nine mutants fall into two categories: 1) Mutations that decrease synthesis of phosphatidylcholine and 2) Mutations that influence fatty acid metabolism. The two categories are tied together by phosphatidylcholine being a regulator of the fatty acid metabolism transcription factor
sbp-1, a homolog of the mammalian SREBP (Walker et al. 2011). Consequently we have been able to connect all nine
paqr-2 suppressor mutants into one pathway, the
paqr-2 target pathway. Also,
fat-6 or -7 RNAi can completely abolish the suppression in mutants from both categories pointing towards an increase in fatty acid desaturation as the common suppressive mechanism.
We conclude that
paqr-2 regulates cold adaptation and that this process is highly dependent on the D9 desaturases. However, despite having identified the
paqr-2 target pathway, the direct action point of this receptor remains unknown.
References: Kadowaki T. et al. (2008) FEBS Lett 582:74-80; Svensson E. et al. (2011) PLoS One 6:
e21343; Tang Y. et al. (2005) J Mol Evol 61:372-380; Walker A. et al. (2011) Cell 147:840-852.